CN108669566A - A kind of functional composition and its application - Google Patents
A kind of functional composition and its application Download PDFInfo
- Publication number
- CN108669566A CN108669566A CN201810205335.5A CN201810205335A CN108669566A CN 108669566 A CN108669566 A CN 108669566A CN 201810205335 A CN201810205335 A CN 201810205335A CN 108669566 A CN108669566 A CN 108669566A
- Authority
- CN
- China
- Prior art keywords
- functional
- parts
- vitamin
- component
- functional composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 229940079593 drug Drugs 0.000 claims abstract description 31
- 239000003814 drug Substances 0.000 claims abstract description 31
- 229940088594 vitamin Drugs 0.000 claims abstract description 24
- 229930003231 vitamin Natural products 0.000 claims abstract description 24
- 235000013343 vitamin Nutrition 0.000 claims abstract description 24
- 239000011782 vitamin Substances 0.000 claims abstract description 24
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 24
- 240000007817 Olea europaea Species 0.000 claims abstract description 22
- 244000068988 Glycine max Species 0.000 claims abstract description 21
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 21
- 230000036541 health Effects 0.000 claims abstract description 21
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 19
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 19
- 239000004615 ingredient Substances 0.000 claims abstract description 19
- 229920001184 polypeptide Polymers 0.000 claims abstract description 17
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 17
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 17
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 16
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 16
- 230000002929 anti-fatigue Effects 0.000 claims abstract description 7
- 235000013305 food Nutrition 0.000 claims description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 14
- 239000008103 glucose Substances 0.000 claims description 14
- 235000002639 sodium chloride Nutrition 0.000 claims description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 9
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 8
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 8
- 229930003471 Vitamin B2 Natural products 0.000 claims description 8
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 8
- 229960002477 riboflavin Drugs 0.000 claims description 8
- 235000019164 vitamin B2 Nutrition 0.000 claims description 8
- 239000011716 vitamin B2 Substances 0.000 claims description 8
- 239000000470 constituent Substances 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
- 239000001301 oxygen Substances 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 4
- 235000019158 vitamin B6 Nutrition 0.000 claims description 4
- 239000011726 vitamin B6 Substances 0.000 claims description 4
- 229940011671 vitamin b6 Drugs 0.000 claims description 4
- 229940100688 oral solution Drugs 0.000 claims description 3
- 235000013376 functional food Nutrition 0.000 abstract description 2
- 230000001151 other effect Effects 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 25
- 238000012360 testing method Methods 0.000 description 22
- 239000000047 product Substances 0.000 description 21
- 230000009182 swimming Effects 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 229920002527 Glycogen Polymers 0.000 description 12
- 229940096919 glycogen Drugs 0.000 description 12
- 239000002253 acid Substances 0.000 description 10
- 230000002440 hepatic effect Effects 0.000 description 10
- 102100026189 Beta-galactosidase Human genes 0.000 description 9
- 206010021143 Hypoxia Diseases 0.000 description 9
- 108010059881 Lactase Proteins 0.000 description 9
- 108010005774 beta-Galactosidase Proteins 0.000 description 9
- 230000007954 hypoxia Effects 0.000 description 9
- 229940116108 lactase Drugs 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 210000004279 orbit Anatomy 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229940023356 vitamin b6 10 mg Drugs 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- -1 salinity Substances 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 241000370738 Chlorion Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229940006460 bromide ion Drugs 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229910001427 strontium ion Inorganic materials 0.000 description 1
- PWYYWQHXAPXYMF-UHFFFAOYSA-N strontium(2+) Chemical compound [Sr+2] PWYYWQHXAPXYMF-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Embodiment of the disclosure provides a kind of functional composition, including basic ingredient, and the basic ingredient includes salinity, vitamin, sugar;Functional component, including the first functional component and/or the second functional component, first functional component include Sessileflower Acanthopanax Bark, sealwort, matrimony vine;The second composition includes soya-bean polypeptides, olive polyphenol.The functional composition that the embodiment of the present disclosure provides as functional health product, functional medicines, functional food etc. at least partly it is antifatigue, regain one's strength, improve constitution and other effects.
Description
Technical field
The embodiment of the present disclosure is related to a kind of functional composition and its application, belongs to medical health field.
Background technology
The intensified competition of modern society, tempo increase are chronically at nervous living environment, and operating pressure is big and excessively tired
Labor so that part population is chronically at the sub-health state of fatigue, over fatigue, constitution difference, brings long-term pathogenic risk.
Therefore, how delay fatigue, dispelling fatigue, regaining one's vigor, improve constitution etc. has urgent demand.
For the demand, the health products form such as drinks, functional food has been greatly developed in recent years, market
On there is various different forms, this kind of product of different levels, to meet different types of health care demand.Common such production
Product include:1, red ox, for supplementing physical efficiency;2, Jia get Le, it is core to supplement water and electrolyte, to meet the physical efficiency of sport people
Expending equilibrium;3, it pulses, for supplementing lot of trace vitamin, improves nutrition;4, lung health is protected in true field, is improved specific
Organ function.
Applicant have observed that many health foods, the drink etc. sold on the market at present, past in order to realize its function
Toward using a variety of parahormone chemical compositions, such as taurine, lysine, caffeine, vitamin etc., these chemical additives are long-term
There may be potential safety, additive risks for intake.
Invention content
Embodiment of the disclosure provides a kind of functional composition and its application, is at least partially and regains one's strength,
Dispelling fatigue nourishes body, improves the function of constitution.
In one aspect of the present disclosure, a kind of functional composition, including basic ingredient, the basic ingredient packet are provided
Include salinity, vitamin, sugar;Functional component, including the first functional component and/or the second functional component, first function at
It includes Sessileflower Acanthopanax Bark, sealwort, matrimony vine to divide;The second composition includes soya-bean polypeptides, olive polyphenol.
Optionally, in the basic ingredient, the dosage number of each component is 0.5-3 parts of salinity, vitamin 0.005-
0.03 part, 5-10 parts of sugar.
Optionally, in first functional component, the dosage number of each component is 2-5 parts of Sessileflower Acanthopanax Bark, sealwort 8-15
Part, 8-15 parts of matrimony vine.
Optionally, in second functional component, the dosage number of each component is 1-3 parts of soya-bean polypeptides, olive polyphenol
0.05-0.3 parts.
Optionally, the functional composition, including basic ingredient, the first functional component and the second functional component, respectively
The dosage number of component be 1 part of salinity, 0.015 part of vitamin, 8 parts of sugar, 4 parts of Sessileflower Acanthopanax Bark, 10 parts of sealwort, 10 parts of matrimony vine,
2 parts of soya-bean polypeptides, 0.1 part of olive polyphenol.
Optionally, the salinity includes sea salt, and the vitamin includes vitamin B2 and/or vitamin B6, the sugar
Including glucose.
In another aspect of the present disclosure, provides above-mentioned functional composition and preparing antifatigue medicine as active constituent
Application in product, health products or food.
In the further aspect of the disclosure, above-mentioned functional composition is provided as active constituent in the medicine for preparing resist oxygen lack
Application in product, health products or food.
Optionally, the drug, health products or food are Oral liquid forms, the mass-volume concentration of functional composition
For 0.1-0.2g/ml.
Optionally, the drug, health products or food are Oral liquid forms, dosage 1-100ml/kg.
The experiment that applicant carries out shows that the functional composition of the embodiment of the present disclosure has the preferable oxygen of resistance to institute and resists tired
Work is used, and showing can regain one's strength faster in short term, improves fatigue, and long-time service can nourish, improve constitution.
Specific implementation mode
To keep the purpose, technical scheme and advantage of the embodiment of the present disclosure clearer, below in conjunction with the embodiment of the present disclosure
Composition, experiment, the technical solution of the embodiment of the present disclosure is clearly and completely described.Obviously, described embodiment is
A part of this disclosure embodiment, instead of all the embodiments.Based on described embodiment of the disclosure, this field is common
The every other embodiment that technical staff is obtained under the premise of without creative work belongs to the model of disclosure protection
It encloses.
The functional composition that each Ingredient Amount mentioned in following embodiments does not provide the disclosure constitutes special
It limits, also not limiting the embodiment of the present disclosure must be realized with mentioned dosage, be only schematically illustrate present disclosure.
In some embodiments, present disclose provides a kind of functional composition, including basic ingredient, the basic ingredients
Including salinity, vitamin, sugar;Functional component, including the first functional component and/or the second functional component, first function
Ingredient includes Sessileflower Acanthopanax Bark, sealwort, matrimony vine;The second composition includes soya-bean polypeptides, olive polyphenol.
For example, salinity also refers to as biologically edible salt, including but not limited to well salt, rock salt, sea salt,
Black salt etc..
For example, salinity also refers to sea salt.
For example, salinity is also referred to by drying the salinity in the seawater that seawater obtains.
For example, salinity also refers to the sea salt with following mass ratio composition:Chlorion 55.03%, sodium ion
30.59%, sulfate radical, 7.68%, magnesium ion 3.68%, calcium ion 1.18%, potassium ion, 1.11%, bicarbonate radical 0.41%,
Bromide ion 0.19%, borate 0.08%, strontium ion 0.04%, other (impurity) 0.01%.
For example, vitamin also refers to the vitamin ingredients that multiple beneficial is needed in function of human body, including but not limited to
Vitamin B complex, D, A, E etc..
For example, vitamin may include vitamin B2 and/or vitamin B6.
For example, sugar also refer to it is various for absorption of human body, decompose to be converted to the carbohydrate of energy, packet
Include but be not limited to glucose, maltose, lactose etc..
For example, sugar may include glucose.
For example, in the first functional component, its crude drug may be used in Sessileflower Acanthopanax Bark, sealwort, matrimony vine, and can also use will
Medicinal material crush after medicinal powder, its extract can also be used.For example, water-soluble or fat-soluble extract;For example, alcohol or/
And water extract.
For example, in the second functional component, soya-bean polypeptides, olive polyphenol can directly use such active ingredient,
Extract of soybean, the olive extract for including these active ingredients may be used, the powder after soybean, olive can also be used to crush
End.
For example, in basic ingredient, the dosage number of each component is 0.5-3 parts of salinity, 0.005-0.03 parts of vitamin, sugar
Divide 5-10 parts.
For example, vitamin includes vitamin B2, vitamin B6, the dosage portion rate of the two is (3-7):(7-15).
For example, in basic ingredient, the dosage number of each component is 1 part of sea salt, 0.005 part of vitamin B2, vitamin
B60.01 parts, 8 parts of glucose.
For example, in the first functional component, the dosage number of each component is 2-5 parts of Sessileflower Acanthopanax Bark, 8-15 parts of sealwort, matrimony vine
8-15 parts.
For example, with crude drug gauge, in the first functional component, the dosage number of each component is 2-5 parts of Sessileflower Acanthopanax Bark, sealwort
8-15 parts, 8-15 parts of matrimony vine.
For example, with crude drug gauge, in the first functional component, the dosage number of each component is 4 parts of Sessileflower Acanthopanax Bark, sealwort 10
Part, 10 parts of matrimony vine.
For example, in the second functional component, the dosage number of each component is 1-3 parts of soya-bean polypeptides, olive polyphenol 0.05-
0.3 part.
For example, in terms of compound amount, in the second functional component, the dosage number of each component be 1-3 parts of soya-bean polypeptides,
0.05-0.3 parts of olive polyphenol.
For example, in terms of compound amount, in the second functional component, the dosage number of each component is 2 parts of soya-bean polypeptides, olive
0.1 part of olive polyphenol.
For example, functional composition, including basic ingredient, the first functional component and the second functional component, the use of each component
Amount number is 1 part of salinity, 0.015 part of vitamin, 8 parts of sugar, 4 parts of Sessileflower Acanthopanax Bark, 10 parts of sealwort, 10 parts of matrimony vine, soya-bean polypeptides 2
Part, 0.1 part of olive polyphenol.
For example, functional composition, including basic ingredient, the first functional component and the second functional component, the use of each component
Amount number is 1 part of sea salt, 0.005 part of vitamin B2,0.01 part of vitamin B6,8 parts of glucose, Sessileflower Acanthopanax Bark (with crude drug amount
Meter) 4 parts, 10 parts of sealwort (with crude drug gauge), 10 parts of matrimony vine (with crude drug gauge), 2 parts of soya-bean polypeptides (with compound gauge), olive
0.1 part of olive polyphenol (with compound gauge).
Embodiment of the disclosure additionally provides the preparation process of above-mentioned functional composition, can be various by the field of Chinese medicines
It is prepared by common technology.
For example, it may be Sessileflower Acanthopanax Bark, sealwort, matrimony vine, soybean, olive etc. are crushed respectively, by powder and salinity,
Sugar, vitamin etc. are mixed.
For example, can be carried to crude drug powders such as Sessileflower Acanthopanax Bark, sealwort, matrimony vine, soybean, olives by water, ethyl alcohol etc.
Extract is obtained, then mixes it with salinity, sugar, vitamin etc..
For example, it may be Sessileflower Acanthopanax Bark, sealwort, matrimony vine etc. are crushed as crude drug, it is more with soya-bean polypeptides, olive
Phenol, salinity, sugar, vitamin etc. are mixed.
Embodiment of the disclosure additionally provide above-mentioned functional composition as active constituent prepare antifatigue drug,
Application in health products or food.
Embodiment of the disclosure additionally provide above-mentioned functional composition as active constituent the drug for preparing resist oxygen lack,
Application in health products or food.
For example, the concrete form of drug, health products or food can be functional composition is used in combination with auxiliary material with
Obtain corresponding dosage form or product form.
For example, auxiliary material may include any nutrition, the biologies such as excipient, antioxidant, PH conditioning agents, preservative, isotonic agent
Acceptable on, the guaranteed auxiliary material of safety.
For example, the concrete form of drug, health products or food can be capsule, tablet, pulvis, granule, oral solution or
Syrup etc., the appearance existence form for changing product belongs to the technical solution that those skilled in the art can associate, therefore changes
The shape of final products belongs to the coverage area of the disclosure.
For example, the drug, health products or food are Oral liquid forms, by mixing functional composition in water
It uniformly obtains, the mass-volume concentration of functional composition is 0.1-0.2g/ml.
For example, the drug, health products or food are Oral liquid forms, dosage 1-100ml/kg.Referred to herein
Dosage refers to the weight relative to organism weight, such as people, in terms of daily, the oral solution dosage volume drunk.
For example, the drug, health products or food are Oral liquid forms, dosage 2-50ml/kg.
For example, the drug, health products or food are Oral liquid forms, dosage 8-40ml/kg.
In order to illustrate the effect of disclosure functional composition, applicant carried out following experiments.
1 materials and methods
1.1 animal subject
SPF grades of kunming mices, male, 20 ± 2g of weight, are provided by Guangdong Province's Experimental Animal Center.Mouse is 18 in temperature
~25 DEG C, relative humidity be 50%~70% environment in raise.
1.2 basal feed
It is provided by Traditional Chinese Medicine University Of Guangzhou's Experimental Animal Center.
1.3 test sample
Blank control group:Distilled water;
Positive controls:Commercially available red ox drinks;
1 group of the side of tearing open:Sessileflower Acanthopanax Bark 4g (crude drug amount), sealwort 10g (crude drug amount), matrimony vine 10g (crude drug amount), glucose 8g,
Sea salt 1g, vitamin B2 5mg, vitamin B6 10mg;
2 groups of the side of tearing open:Soya-bean polypeptides 2g, olive polyphenol 100mg, glucose 8g, sea salt 1g, vitamin B2 5mg, vitamin
B6 10mg。
Test group:Sessileflower Acanthopanax Bark 4g (crude drug amount), sealwort 10g (crude drug amount), matrimony vine 10g (crude drug amount), soya-bean polypeptides 2g,
Olive polyphenol 100mg, glucose 8g, sea salt 1g, vitamin B2 5mg, vitamin B6 10mg.
The above-mentioned side's of tearing open combination and test group are prepared as 250ml oral solutions.
1.4 reagents and instrument
Blood lactase acid assay kit, serum urea nitrogen assay kit are built up institute of biological products by Nanjing and are provided.
722 type spectrophotometers, XHF-1 types high speed disperser are provided by Traditional Chinese Medicine University Of Guangzhou experimental center.
1.5 experimental method
It presses《Function of health food assessment process and the method for inspection》It carries out.
1.5.1 experimental animal is grouped
Dosage grouping is equivalent to 2ml/kg according to daily life function beverage human intaking amount 120ml/d by 60kg batheroom scales,
Folding and the equivalent dose conversion coefficient of mouse are 9.1, are equivalent to 18.2ml/kg, and test group is designed by 0.5,1,2 times of equivalent
1,2 group of basic, normal, high three dosage group, " red ox " positive controls and the side of tearing open are designed by 1 times of equivalent, as follows:
(1) blank control group:18.2ml/kg
(2) positive controls:18.26ml/kg
(3) 1 group of the side of tearing open:18.2ml/kg
(4) 2 groups of the side of tearing open:18.2ml/kg
(5) test group low dosage:9.1ml/kg
(6) test group middle dosage:18.2ml/kg
(7) test group high dose:36.4ml/kg
1.5.2 hypoxia endurance test method
Tested material 30d continuously is given, each group mouse is respectively put into and fills 15g sodium stones by the 1h after last gives tested material
In the 250mL wide-mouth bottle of ash (every bottle only puts 1 mouse), bottleneck is smeared with vaseline, covers tightly, is allowed to air tight, immediately timing,
Stopped as index with breathing, the observation mouse time dead due to anoxic.
1.5.3 swimming with a load attached to the body is tested
Continuous to give tested material 30d, after test last is to sample 30min, the sheet lead of mouse 5% weight of heavy burden is placed in water temperature
25 DEG C, the water tank went swimming of 35~40cm of the depth of water, record mouse from swimming to the time of death, when swimming as mouse
Between (min).
1.5.4 the measurement of blood lactase acid
1.5.4.1 blood lactase acid measures before swimming
It is grouped and to sample:Same 1.5.2, last give sample 30min posterior orbits blood sampling, take serum with 722 type spectrophotometers into
Row Plasma lactate.
1.5.4.2 0min blood lactase acids measure after swimming
It is grouped and to the same 1.5.2 of sample.Last is adopted to the water went swimming 90min in 30 DEG C of temperature after sample 30min, immediately eye socket
Blood takes serum to carry out Plasma lactate with 722 spectrophotometers.
1.5.4.3 30min blood lactase acids measure after swimming
It is grouped and to the same 1.5.2 of sample.Last is to water the went swimming 90min, rest 30min in 30 DEG C of temperature after sample 30min
Eye socket is taken a blood sample immediately afterwards, and serum is taken to carry out Plasma lactate with 722 spectrophotometers.
1.5.4.4 the measurement of serum urea nitrogen
It is grouped and to sample:Same 1.5.2.Last to after sample 30min after the water went swimming 90min of 30 DEG C of temperature, eye immediately
Socket of the eye is taken a blood sample, and serum is taken to carry out determination of urea nitrogen with 722 spectrophotometers.
1.5.4.5 the measurement of hepatic glycogen
It is grouped and to sample:Same 1.5.2.Last is put to death immediately to the water went swimming 90min in 30 DEG C of temperature after sample 30min,
Liver is taken to be blotted with filter paper after physiological saline rinses.Liver 100mg is weighed, 8mL TCA are added, 1min is homogenized, by homogenate
Centrifuge tube is poured into, 15min is centrifuged with 3000r/min, supernatant 1mL is taken, adds 95% ethyl alcohol 4mL, mix well to two kinds of liquid
Between there are interfaces, beyond the Great Wall with clean plug, at room temperature erect stand overnight.Next day centrifuges 15min with 3000r/min.Carefully
It outwells supernatant and test tube is made to stand upside down and place 10min.Glycogen is dissolved with 2mL distilled water.Reagent blank pipe:2mL distilled water is inhaled to arrive
Clean centrifuge tube standard pipe:It inhales 0.5mL glucose standards (100mg/dL) and 1.5mL distilled water is put into same pipe.It will
Each pipe is added in 10mL anthrone reagents, boils 15min, then moves on to ice-water bath and uses reagent blank after cooling under 620nm wavelength
Absorbance is measured after pipe zeroing.Hepatic glycogen content is calculated as follows:
Hepatic glycogen (mg/100g livers)=(DU/DS) × 0.5 × (V/G) × 100 × 0.9
In formula:DU --- sample cell absorbance;V --- extracting liquid volume (mL);DS --- standard pipe absorbance;
0.5 --- the glucose content in 0.5mL glucose standards;G --- hepatic tissue weight (g);0.9 --- glucose is converted
At the coefficient of glycogen.
1.6 data processing
Data statistic analysis is carried out with SPSS10.0 for windows.
2 results and analysis
Influence of 2.1 drinks to mouse weight
Influence (X ± SD) of 1 drinks of table to mouse weight
As shown in Table 1, after mouse einnehmen function beverage 30d, mouse weight is compared with the control group without significant difference (p>
0.05).Each group will not cause weight excessively rapid growth, will not inhibit the normal development of mouse.
Influence of 2.2 drinks to mouse hypoxia-bearing capability
Influence (X ± SD) of 2 drinks of table to mouse hypoxia-bearing capability
*:With blank control group ratio, P<0.05;#:Ratio, P are organized with red ox control group, the side of tearing open<0.05
**:With blank control group ratio, P<0.01;##:Ratio, P are organized with red ox control group, the side of tearing open<0.01
Anoxic is a kind of pessimal stimulation to body, influences the various metabolism of body, as can be seen from Table 2,6 groups of drinks and blank
Control group can more significantly improve mouse hypoxia-bearing capability (P<0.01).Meanwhile each dosage group of test group and red ox control group,
The side's of tearing open control group ratio, significant difference, prompt test group group to be substantially better than in terms of hypoxia-bearing capability red ox control group and
The side's of tearing open control group.
Influence of 2.3 drinks to the mice burden swimming time
Influence (X ± SD) of 3 drinks of table to the mice burden swimming time
*:With blank control group ratio, P<0.05;#:Ratio, P are organized with red ox control group, the side of tearing open<0.05
**:With blank control group ratio, P<0.01;##:Ratio, P are organized with red ox control group, the side of tearing open<0.01
As shown in Table 3, after gavaging drinks 30d, there is significant extension (p in each group mice burden swimming time<0.05).
For wherein high, middle dose group compared with red ox and the side's of tearing open group control group, the extension time is longer, there is notable difference (P<0.05) it, shows
Influence of the test group to the mice burden swimming time will be substantially better than red ox and the side's of tearing open control group.
Influence of 2.4 drinks to mouse movement biochemical indicator
Influence (X ± SD) of 4 drinks of table to mouse blood lactase acid
*:With blank control group ratio, P<0.05;#:Ratio, P are organized with red ox control group, the side of tearing open<0.05
**:With blank control group ratio, P<0.01;##:Ratio, P are organized with red ox control group, the side of tearing open<0.01
As shown in table 4, the measurement of blood lactase acid, after swimming after 0min and 30min, other than 1 group of the side of tearing open, remaining each group function
Beverage mouse blood lactase acid is significantly lower than blank control group (p < 0.01), the high, medium and low dosage group of test group and red ox control group
Compare no significant difference between 2 groups of the side of tearing open.
Influence (X ± SD) of 5 drinks of table to mice serum urea nitrogen, hepatic glycogen
*:With blank control group ratio, P<0.05;#:Ratio, P are organized with red ox control group, the side of tearing open<0.05
**:With blank control group ratio, P<0.01;##:Ratio, P are organized with red ox control group, the side of tearing open<0.01
Shown in table 5, the urea nitrogen levels of 1 group of the middle and high dosage of test group and the side of tearing open are significantly lower than blank control group and red ox
Control group (P<0.01);The hepatic glycogen content of 1 group of the basic, normal, high dosage of test group and the side of tearing open is apparently higher than blank control group and red
Ox control group.As it can be seen that violent fortune has also been effectively relieved while helping to improve mouse hepatic glycogen reserve in test group drinks
The dynamic protein metabolism occurred.
3. conclusion
3.1 above-mentioned experiments show, the functional composition mouse hypoxia-bearing capability that the embodiment of the present disclosure provides and blank pair
It is compared according to group, death time difference extremely significantly (P<0.01).The hypoxia-bearing capability of mouse can be improved by illustrating two kinds of drinks,
Can enhance the function that body resists this poor environment of anoxic, and test group hypoxia-bearing capability be significantly better than it is other.
3.2 by 3~table of table 5 as it can be seen that in a series of antifatigue experiments, the functional composition experimental result of the disclosure is
The positive, and difference extremely significantly (P<0.01).By table 3 as it can be seen that in Loaned swimming test, walking weight load is considerably longer than blank
Control group, and while the hypoxia-bearing capability of test group be significantly better than it is other.By table 4 as it can be seen that the functional composition of the disclosure is small
The accumulation of blood lactase acid is significantly lower than blank control group (P in mouse body<0.01) aerobic capacity, can be obviously increased, breast is promoted
Acid metabolic.As seen from Table 5, the functional composition mouse of the disclosure is after swimming, and internal hepatic glycogen is obviously improved, and test group
Higher than blank control group, red ox control group and 2 groups of the side of tearing open (P<0.01), serum urea nitrogen level significantly lower than blank control group,
Red ox control group and 2 groups of the side of tearing open (P<0.01), display test group group drinks can increase the storage level of hepatic glycogen, hepatic glycogen storage
Standby increase can maintain the blood glucose level of long period, and more energy are provided for body, reduce glycogen after intense physical labour
Consumption, to promote physical efficiency, enhancing endurance, antifatigue effect.
3.3 during above-mentioned experiment, and the functional composition of the disclosure is applied does not occur ill-effect in mouse.
3.4 according to experimental result, shows that the functional composition of the disclosure has the function of having resist oxygen lack, antifatigue, and
And the effect of test group be substantially better than it is other.
Obviously, those skilled in the art can carry out the disclosure essence of the various modification and variations without departing from the disclosure
God and range.In this way, if these modifications and variations of the disclosure belong to the range of disclosure claim and its equivalent technologies
Within, then the disclosure is also intended to include these modifications and variations.
Claims (10)
1. a kind of functional composition, it is characterised in that including basic ingredient, the basic ingredient includes salinity, vitamin, sugar
Point;Functional component, including the first functional component and/or the second functional component, first functional component include Sessileflower Acanthopanax Bark, Huang
Essence, matrimony vine;The second composition includes soya-bean polypeptides, olive polyphenol.
2. functional composition according to claim 1, it is characterised in that in the basic ingredient, the dosage of each component
Number is 0.5-3 parts of salinity, 0.005-0.03 parts of vitamin, 5-10 parts of sugar.
3. functional composition according to claim 1, it is characterised in that in first functional component, each component
Dosage number is 2-5 parts of Sessileflower Acanthopanax Bark, 8-15 parts of sealwort, 8-15 parts of matrimony vine.
4. functional composition according to claim 1, it is characterised in that in second functional component, each component
Dosage number is 1-3 parts of soya-bean polypeptides, 0.05-0.3 parts of olive polyphenol.
5. functional composition according to claim 1, it is characterised in that including basic ingredient, the first functional component and
The dosage number of two functional components, each component is 1 part of salinity, 0.015 part of vitamin, 8 parts of sugar, 4 parts of Sessileflower Acanthopanax Bark, sealwort 10
Part, 10 parts of matrimony vine, 2 parts of soya-bean polypeptides, 0.1 part of olive polyphenol.
6. functional composition according to claim 1, it is characterised in that the salinity includes sea salt, the vitamin packet
Vitamin B2 and/or vitamin B6 are included, the sugar includes glucose.
7. functional composition described in claim 1 is preparing antifatigue drug, health products or food as active constituent
In application.
8. functional composition described in claim 1 is as active constituent in the drug, health products or food for preparing resist oxygen lack
In application.
9. application according to claim 7 or 8, it is characterised in that the drug, health products or food are the oral solution bodily form
The mass-volume concentration of formula, functional composition is 0.1-0.2g/ml.
10. application according to claim 9, it is characterised in that the drug, health products or food are Oral liquid forms,
Dosage is 1-100ml/kg.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810205335.5A CN108669566A (en) | 2018-03-13 | 2018-03-13 | A kind of functional composition and its application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810205335.5A CN108669566A (en) | 2018-03-13 | 2018-03-13 | A kind of functional composition and its application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108669566A true CN108669566A (en) | 2018-10-19 |
Family
ID=63800037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810205335.5A Pending CN108669566A (en) | 2018-03-13 | 2018-03-13 | A kind of functional composition and its application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108669566A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114831183A (en) * | 2022-05-12 | 2022-08-02 | 甘南倍益特生物科技有限公司 | Altitude stress resistant formula milk powder and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101284041A (en) * | 2008-05-30 | 2008-10-15 | 吉林大学 | A compound astragalus traditional Chinese medicine preparation with health care function and its preparation process |
| CN100493584C (en) * | 2007-05-31 | 2009-06-03 | 杨万政 | A kind of traditional Chinese medicine composition with anti-fatigue effect |
| CN104010524A (en) * | 2011-12-06 | 2014-08-27 | 爱尔兰浓缩加工公司 | Fatigue-relieving herbal extracts and beverages comprising same |
| CN106359755A (en) * | 2016-09-05 | 2017-02-01 | 四川省中医药科学院 | Health-care coarse grain tea, preparation method and application thereof |
| CN106942385A (en) * | 2017-03-23 | 2017-07-14 | 黑龙江省北大荒绿色健康食品有限责任公司 | A kind of preparation method of anti-fatigue effect soy milk powder |
| CN107252114A (en) * | 2017-07-01 | 2017-10-17 | 马南行 | A kind of composition of strengthen immunity anti-aging and preparation method thereof |
-
2018
- 2018-03-13 CN CN201810205335.5A patent/CN108669566A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100493584C (en) * | 2007-05-31 | 2009-06-03 | 杨万政 | A kind of traditional Chinese medicine composition with anti-fatigue effect |
| CN101284041A (en) * | 2008-05-30 | 2008-10-15 | 吉林大学 | A compound astragalus traditional Chinese medicine preparation with health care function and its preparation process |
| CN104010524A (en) * | 2011-12-06 | 2014-08-27 | 爱尔兰浓缩加工公司 | Fatigue-relieving herbal extracts and beverages comprising same |
| CN106359755A (en) * | 2016-09-05 | 2017-02-01 | 四川省中医药科学院 | Health-care coarse grain tea, preparation method and application thereof |
| CN106942385A (en) * | 2017-03-23 | 2017-07-14 | 黑龙江省北大荒绿色健康食品有限责任公司 | A kind of preparation method of anti-fatigue effect soy milk powder |
| CN107252114A (en) * | 2017-07-01 | 2017-10-17 | 马南行 | A kind of composition of strengthen immunity anti-aging and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 任晓枫,等: "无梗五加药效研究", 《中国中医药科技》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114831183A (en) * | 2022-05-12 | 2022-08-02 | 甘南倍益特生物科技有限公司 | Altitude stress resistant formula milk powder and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104187952B (en) | Ginseng-sealwort composite sports health beverage | |
| CN103750339B (en) | Saussurea involucrate culture health-care food and application thereof | |
| CN104026563A (en) | Composition having muscle power fatigue alleviating and anoxic tolerance improving effects, and preparation method thereof | |
| WO2023226315A1 (en) | Anti-fatigue traditional chinese medicine compound composition | |
| Dudgeon et al. | The effects of high and low-dose Cordyceps militaris—Containing mushroom blend supplementation after seven and twenty-eight days | |
| CN106820093A (en) | A kind of energy glue used suitable for marathon and running exercise and preparation method thereof | |
| CN101248880A (en) | Anti-fatigue sports beverage and preparation method thereof | |
| CN107212401A (en) | Composition for relieving physical fatigue and its preparation and preparation method | |
| CN105902998A (en) | Liver protecting capsules | |
| WO2016141775A1 (en) | Uses of jilin ginseng oligopeptide in preparing food product or healthcare food product for combating fatigue | |
| CN109170907A (en) | A kind of preparation method of composition containing NMN, application and sports drink | |
| CN102106890B (en) | Applications and preparation method of saussurea total sesquiterpene lactone | |
| CN104388236A (en) | Grape wine as well as preparation method and application thereof | |
| KR20140016863A (en) | Anti-fatigue composition of plant material and preparation method, use and products thereof | |
| CN101156877A (en) | A sobering-up agent | |
| CN108669566A (en) | A kind of functional composition and its application | |
| US20100173822A1 (en) | Composition comprising saccarides & peptides & uses thereof | |
| CN102008083B (en) | Health food for alleviating physical fatigue and removing chloasma | |
| CN113424895A (en) | Formula of tablet candy with function of assisting in reducing uric acid | |
| CN113209217A (en) | Traditional Chinese medicine composition for resisting physical fatigue and preparation method thereof | |
| CN103202506B (en) | One produces refreshing effect to the mind plant beverage and production method thereof | |
| CN102885311A (en) | Composite health food composition for alleviating physical fatigue and preparation method thereof | |
| CN106924548A (en) | The medicine and preparation method of a kind of fatigue-relieving | |
| CN111297963A (en) | A kind of hangover and liver protection extract, composition and preparation method and application | |
| CN104839846A (en) | Ginseng functional health sports drink and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181019 |